Document is current
Any future updates will be listed below
-
Authors
Kamitani, Tsukasa
Fukuma, Shingo
Shimizu, Sayaka
Akizawa, Tadao
Fukuhara, Shunichi
-
Funding
Funding for this research was provided by:
Amgen
Kyowa Hakko Kirin
Sanofi/Genzyme
Abbott
Baxter
Vifor Fresenius Renal Pharma
- License Information
-
More Information
Article History
Received: 22 May 2019
Accepted: 30 December 2019
First Online: 8 January 2020
Ethics approval and consent to participate
: All patients provided written informed consent, and the study protocol was approved by the institutional review board of Kyoto University Graduate School and Faculty of Medicine, Ethics Committee (R1301).
: Not applicable.
: Shi.F., T.A., and Shu.F. have acted as scientific advisors to Kyowa Hakko Kirin. T.A. has received personal fees from Bayer Health Care, Astellas, JT Corporation, Torii Pharma, Ono Pharma, Kissei Pharma, and Chugai Pharma outside the submitted work. T.K. and S.S. declare that they have no competing interests.
